5-Amino-1MQ vs Tesamorelin: Which Cuts Fat Faster?

Built by medical professionals, gym rats, and experienced biohackers

Tesamorelin has stronger human evidence and works by boosting growth hormone to reduce deep belly fat. 5-Amino-1MQ is earlier-stage and works by blocking an enzyme that promotes fat storage. The right pick depends heavily on how much evidence you need before trying something.

Quick Answer
5-Amino-1MQ blocks the NNMT enzyme to slow fat storage, while Tesamorelin triggers growth hormone release to reduce visceral (deep belly) fat. Tesamorelin has FDA approval and multiple clinical trials; 5-Amino-1MQ is mostly animal research. If evidence level matters to you, Tesamorelin is the stronger pick.

What Is 5-Amino-1MQ?

5-Amino-1MQ is a small synthetic molecule, not technically a peptide. It blocks an enzyme called NNMT (nicotinamide N-methyltransferase).

NNMT is found in fat tissue and may regulate how efficiently cells burn energy. Animal studies suggest blocking it reduces fat mass and raises the metabolic rate, even without cutting calories (source).

Human data is very limited. It is not FDA approved for any use.

What Is Tesamorelin?

Tesamorelin is a synthetic version of GHRH, the hormone your brain uses to tell the pituitary gland to release growth hormone (GH).

Higher GH levels are linked to reduced visceral fat (the fat that sits around your organs). The FDA approved Tesamorelin specifically to reduce this belly fat in adults with HIV-related fat redistribution (lipodystrophy) (source).

It is also studied off-label for general visceral fat reduction in people without HIV.

How Do 5-Amino-1MQ and Tesamorelin Differ?

How does each one work?

5-Amino-1MQ targets NNMT, an enzyme involved in fat cell metabolism. Blocking it may make fat cells less efficient at storing energy .

Tesamorelin works by raising growth hormone. GH then acts on fat cells to break down stored visceral fat.

These are completely different mechanisms.

What do people use each one for?

5-Amino-1MQ is discussed for general fat loss and metabolic support, especially in people interested in cutting-edge research compounds.

Tesamorelin is discussed primarily for reducing stubborn visceral (abdominal) fat, and for general GH support.

What are the typical research doses?

5-Amino-1MQ animal studies use around 50 to 200 mg per day . Human dosing protocols are not established.

Tesamorelin is typically dosed at 1 to 2 mg per day by subcutaneous injection (a shot under the skin) (source).

How long until you see results?

Tesamorelin showed significant reductions in visceral fat over 26 weeks in clinical trials .

5-Amino-1MQ onset in humans is unknown, since no solid human timeline data exists.

How strong is the evidence?

Tesamorelin has multiple randomized controlled trials and FDA approval. That is a high bar.

5-Amino-1MQ is mostly animal research. Its human safety and efficacy data are thin.

How Do They Compare Side by Side?

Feature	5-Amino-1MQ	Tesamorelin
Type	Small molecule (NNMT inhibitor)	Synthetic GHRH peptide
Main target	NNMT enzyme in fat tissue	Pituitary gland, GH axis
Primary use discussed	General fat loss, metabolism	Visceral fat reduction
Research dose	50 to 200 mg/day [verify]	1 to 2 mg/day [verify]
Typical onset	Unknown in humans	Weeks to months [verify]
Human evidence	Very limited	Strong (FDA approved)
How it is given	Oral or injection	Subcutaneous injection
FDA status	Not approved	Approved (specific indication)

Can You Stack Them?

Some people use 5-Amino-1MQ and Tesamorelin together. The reasoning is that they work through separate pathways: one targeting enzyme activity in fat cells, the other targeting the GH axis.

No stacking research exists . This is general guidance, not personalized medical advice. Consult a licensed clinician before combining any compounds.

Which Do People Pick, and When?

People who want the most evidence-backed option go with Tesamorelin. It has a real clinical track record, especially for visceral fat.

People who are comfortable being on the frontier of research and want to explore NNMT inhibition may be interested in 5-Amino-1MQ.

A few people run both, targeting different mechanisms at once. This is general community guidance, not personalized advice.

If you are running multiple compounds at different doses on different schedules, tracking matters. DoseVault is built for exactly this: logging what you take, when you take it, and what you notice along the way.

Frequently Asked Questions

What is 5-Amino-1MQ?

5-Amino-1MQ is a small synthetic molecule that blocks an enzyme called NNMT (nicotinamide N-methyltransferase). Animal studies suggest blocking NNMT may reduce fat storage and speed up metabolism. Human data is very limited.

What is Tesamorelin?

Tesamorelin is a synthetic peptide that mimics growth-hormone-releasing hormone (GHRH). It signals the pituitary gland to release more growth hormone. The FDA approved it to reduce excess visceral fat in adults with HIV-associated lipodystrophy.

Which has more human evidence, 5-Amino-1MQ or Tesamorelin?

Tesamorelin has far more human evidence. It has FDA approval backed by multiple clinical trials. 5-Amino-1MQ has mostly animal data with very limited human research available.

Can you stack 5-Amino-1MQ and Tesamorelin?

Some people use both, arguing that NNMT inhibition and GH-driven fat metabolism work through different pathways. No published stacking research exists. This is general guidance, not personalized medical advice.

Disclaimer

This article is for educational purposes only and is not medical advice. 5-Amino-1MQ is not FDA approved. Tesamorelin is FDA approved only for its specific indication. Do not use any compound to diagnose, treat, cure, or prevent any condition. Always consult a licensed clinician before starting any compound.

Built by medical professionals, gym rats, and experienced biohackers

Want to log your fat-loss protocol and track your results? DoseVault helps you stay consistent and see patterns across every cycle.